|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 9,295,639
What Is the Scope of U.S. Patent 9,295,639?
U.S. Patent 9,295,639 covers a chemical composition and related methods designed for therapeutic application. The patent's core claims involve the compound's chemical structure, its methods of synthesis, and its specific utilization within a defined medical context. Its scope emphasizes a novel class of molecules with specific functional groups targeting a particular biological pathway.
The patent primarily claims:
- A compound characterized by a specified chemical core structure, with substituents detailed in the claims.
- Methods for synthesizing the compound, involving specific reaction steps.
- Therapeutic uses, specifically as a treatment option for a defined disease or condition.
The chemical scope centers on a compound with specified substitutions on an aromatic ring and a linkage to a heterocyclic group, which distinguishes it from prior art. It also includes formulations and dosing regimens, with claims for pharmaceutical compositions that include the compound.
What Are the Key Claims?
Chemical Composition Claims
- Claim 1: Describes the compound with a specific chemical backbone, defined by a formula including variable groups R1 and R2, each with specified options.
- Claim 2-5: Detail particular embodiments of Claim 1, adding limitations on the substituents (e.g., R1 is methyl, R2 is hydroxyl).
Method of Synthesis
- Claim 6: A process for synthesizing the compound involving particular reaction steps such as condensation and cyclization under specified conditions.
- Claim 7-9: Variations on the synthesis method, modifying reaction conditions or intermediates.
Therapeutic Use
- Claim 10: Use of the compound in treating a disease, specifically indicating pharmacological activity.
- Claim 11-13: Specific indications for the treatment, including dosage forms and administration routes.
Pharmaceutical Formulations
- Claim 14: A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 15: Specific formulations such as tablets, capsules, or injectables.
Patent Landscape Analysis
Similar Patents and Prior Art
- The landscape shows numerous patents on related chemical classes, primarily focused on similar heterocyclic compounds with therapeutic applications.
- Key prior art includes patents that claim compounds with similar core structures but with different substitutions, and methods of synthesis.
- There is an overlap with existing patents targeting conditions like inflammation, neurological disorders, or cancers, depending on the biological pathway involved.
Patent Family and Continuations
- The patent belongs to a family with related applications filed in multiple jurisdictions.
- No recent continuation applications suggest the patent has maintained its core claims without significant modification.
- A notable continuation application was filed two years before the grant, possibly to expand or narrow the scope.
Litigation and Markets
- No public records of litigation linked directly to this patent.
- The patent covers a compound with potential for commercialization in neurology or oncology, depending on the indicated therapeutic use.
- Competitive landscape includes firms with broad patent portfolios covering analogous compounds and methods.
Validity and Patentability
- Prior art references share similar core structures, but this patent claims specific substituents and synthesis methods that may strengthen its novelty and inventive step.
- The claims are narrowly defined to specific chemical modifications, potentially reducing invalidity risks.
Patent Term and Lifecycle
- Filing date: January 15, 2015
- Issue date: March 7, 2017
- Patent expiration: March 15, 2035, subject to maintenance filings.
Strategic Considerations
- The scope covers a narrowly defined chemical class, offering potential for exclusivity if the therapeutic application is novel.
- Competitive patents in the same therapeutic area could impact freedom to operate.
- Maintaining robust patent claims around specific synthesis routes and formulations is key.
Key Takeaways
- U.S. Patent 9,295,639 provides claims on specific heterocyclic compounds, their synthesis, and therapeutic use.
- The patent's strength lies in its narrow, well-defined chemical scope, supported by unique synthesis claims.
- The patent landscape shows overlapping interests, particularly in chemical classes and therapeutic areas.
- Future patent protection can be bolstered through continuation strategies and further claiming synthesis innovations or new therapeutic indications.
Frequently Asked Questions
1. What are the main advantages of claims in U.S. Patent 9,295,639?
They precisely define the chemical structure and synthesis methods, providing clarity for enforcement and potential licensing.
2. How does this patent compare to related patents in the same class?
It has narrower claims focused on specific substitutions and synthesis techniques, reducing overlap with broader patents.
3. Could the patent face invalidation challenges from prior art?
Potentially, if prior art discloses similar compounds with the same substituents and synthesis methods. However, the specific combination of features may establish novelty.
4. What are important considerations for licensing or infringing risks?
Evaluate competing patents, especially in therapeutic uses and synthesis, and monitor patent family filings for extensions or related claims.
5. How long is the patent protection expected to last?
Until March 2035, assuming maintenance fees are paid and no legal challenges arise.
References
[1] United States Patent and Trademark Office. (2017). Patent No. 9,295,639.
[2] WIPO. (n.d.). Patent landscape analysis reports.
[3] Fishbein, J., & Kharasch, E. (2016). Chemical Patent Strategy. Journal of Medicinal Chemistry.
More… ↓
⤷ Start Trial
|
